S. Luo

发表

Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800.

C. Labrie, F. Labrie, A. Bélanger, 1997, Endocrinology.

Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050)

C. Labrie, F. Labrie, A. Bélanger, 1998, Breast Cancer Research and Treatment.

Morphological Changes Induced by 6-Month Treatment of Intact and Ovariectomized Mice with Tamoxifen and the Pure Antiestrogen EM-800.

C. Labrie, F. Labrie, Alain Be Langer, 1997, Endocrinology.

Combined Effects of Dehydroepiandrosterone and EM-800 on Bone Mass, Serum Lipids, and the Development of Dimethylbenz(A)Anthracene-Induced Mammary Carcinoma in the Rat.

C. Labrie, F. Labrie, Alain Be Langer, 1997, Endocrinology.

Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat.

C. Labrie, F. Labrie, A. Bélanger, 1997, Endocrinology.

Long‐term inhibitory effects of a novel anti‐estrogen on the growth of ZR‐75‐1 and MCF‐7 human breast cancer tumors in nude mice

C. Labrie, F. Labrie, C. Martel, 1997, International journal of cancer.

Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity.

C. Labrie, F. Labrie, C. Martel, 1997, Urology.

Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice.

C. Labrie, F. Labrie, A. Bélanger, 1998, Endocrinology.

Inhibitory effect of the novel anti‐estrogen EM‐800 and medroxyprogesterone acetate on estrone‐stimulated growth of dimethylbenz[a]anthracene‐induced mammary carcinoma in rats

C. Labrie, F. Labrie, S. Luo, 1997, International journal of cancer.

Comparative effects of 28‐day treatment with the new anti‐estrogen EM‐800 and tamoxifen on estrogen‐sensitive parameters in intact mice

C. Labrie, F. Labrie, C. Martel, 1997, International journal of cancer.

EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium

Virgile Richard, J. Simard, V. Giguère, 1999, The Journal of Steroid Biochemistry and Molecular Biology.

Relative potencies of Flutamide and Casodex: preclinical studies

J. Simard, C. Labrie, F. Labrie, 1996 .

Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities.

J. Simard, V. Giguère, C. Labrie, 2001, Advances in protein chemistry.

Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.

C. Labrie, F. Labrie, A. Bélanger, 1997, Endocrinology.

Effect of Dehydroepiandrosterone on Bone Mass, Serum Lipids, and Dimethylbenz(a)anthracene-Induced Mammary Carcinoma in the Rat.

C. Labrie, F. Labrie, Alain Be Langer, 1997, Endocrinology.

Opposite effects of prolactin and corticosterone on the expression and activity of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in rat skin.

J. Simard, Y. Labrie, F. Labrie, 1994, The Journal of investigative dermatology.

Opposite effects of prolactin and corticosterone on the expression and activity of 3β-hydroxysteroid dehydrogenase/δ5-δ4 isomerase in rat skin

J. Simard, Y. Labrie, F. Labrie, 1994 .

Comparative effects of 28‐day treatment with the new anti‐estrogen EM‐800 and tamoxifen on estrogen‐sensitive parameters in intact mice

C. Labrie, F. Labrie, C. Martel, 1997, International journal of cancer.